Australia clears Kimberly-Clark's acquisition of Kenvue but requires Carefree, Stayfree divestment
Australia clears Kimberly-Clark's acquisition of Kenvue but requires Carefree, Stayfree divestment Sept 2 (Reuters) - Australia's competition regulator on Wednesday approved Kimberly-Clark's KMB.O proposed $40 billion takeover of Kenvue KVUE.N, on condition the company divests Kenvue's Carefree and Stayfree period care brands in the country to address competition concerns.
Here are the details:
The Australian Competition and Consumer Commission (ACCC) said the period care brands should be divested to an approved purchaser.
The regulator said without the divestment, the deal could lessen competition in period care products supply, with both companies being two of the three major suppliers of period care products in Australia.
The deal, announced in November, would allow Kimberly-Clark to bring in Kenvue's famous global brands such as Listerine mouthwash and Neutrogena, but would expose the company to lawsuits Kenvue faces over Tylenol.
Kimberly-Clark has also sought approval from EU regulators for the takeover, documents on the EU Commission's website showed last week.
"The divestiture will preserve an independent competitor in the supply of period care products in Australia and maintain the competition that would otherwise be lost through the acquisition," ACCC Commissioner Philip Williams said.
(Reporting by Nichiket Sunil in Bengaluru; Editing by Subhranshu Sahu)
((Nichiket.Sunil@thomsonreuters.com;))
Recent news on Kenvue
See all newsBrief: Kenvue To Announce Third Quarter 2026 Results On October 30, 2026
Brief: Kimberly-Clark Corporation Announces Pricing Of $4.9 Billion Private Offering Of Senior Notes
Kenvue loses bid for rehearing after Tylenol autism lawsuits revived (updated)
Media: Kimberly-Clark offers bonds to help fund Kenvue takeover - Bloomberg News
US stocks weekly: AI unwind